Catalyst Wire Dossier Catalyst Wire Dossier

SYMLINPEN

PRAMLINTIDE ACETATE · AstraZeneca Pharmaceuticals LP
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for SYMLINPEN, covering 2007-09-25 to 2019-12-18. Get the full timeline:

Most recent: FDA Approved: SYMLINPEN — Supplemental Application (AstraZeneca Pharmaceuticals LP)

See pricing